<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590361/" ref="ordinalpos=4078&amp;ncbi_uid=4709289&amp;link_uid=PMC3590361" image-link="/pmc/articles/PMC3590361/figure/Fig1/" class="imagepopup">Fig. 1.  From: LPS and PAN-induced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile. </a></div><br /><div class="p4l_captionBody">Schematic representation of major TLR signaling pathways. The toll-like receptor (TLR) signaling pathways converge through two major signaling molecules, MyD88 or TRIF. The MyD88-dependent pathway activates NF-κB and transcription of inflammatory cytokines. The TRIF pathway leads to transcription of type I Interferons. [MyD88: myeloid differentiation primary-response protein 88, IFN: Interferon, IRF-3: IFN-regulatory factor-3, NF-κB: Nuclear factor-κB, LRR: leucine rich repeats, TIR: Toll/interleukin-1 receptor, TRIF: TIR-domain-containing adaptor protein inducing IFN-β]</div></div>